Novartis AG (NVS)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 105.33 |
| Open | 105.07 |
| Bid | 105.27 x 800 |
| Ask | 107.56 x 800 |
| Day's Range | 104.78 - 105.46 |
| 52 Week Range | 92.19 - 108.78 |
| Volume | |
| Avg. Volume | 1,502,395 |
| Market Cap | 217.853B |
| Beta (5Y Monthly) | 0.50 |
| PE Ratio (TTM) | 23.95 |
| EPS (TTM) | 4.40 |
| Earnings Date | Jul 18, 2024 |
| Forward Dividend & Yield | 3.78 (3.59%) |
| Ex-Dividend Date | Mar 07, 2024 |
| 1y Target Est | 111.91 |
ZacksWhy Novartis (NVS) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ZacksWhy Novartis (NVS) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ZacksNovartis (NVS) Reports Positive Long-Term Data on CSU Drug
Novartis (NVS) reports phase III data that confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria.
© 2024 Yahoo. All rights reserved.